Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-April 2011 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-April 2011 Volume 2 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells

  • Authors:
    • Lon D. Ridgway
    • Michael D. Wetzel
    • Dario Marchetti
  • View Affiliations / Copyright

    Affiliations: Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA, Department of Pathology and Immunology, Baylor College of Medicine, BCM - Taub Bldg., Suite T240A, Mail stop 315, One Baylor Plaza, Houston, TX 77030, USA
  • Pages: 229-237
    |
    Published online on: December 28, 2010
       https://doi.org/10.3892/etm.2010.189
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The pathogenesis of medulloblastoma (MB), the most common and aggressive brain tumor in children, is poorly understood. MB tumors respond to factors secreted by cerebellar Purkinje neurons, such as Sonic hedgehog (Shh) and Wingless-type MMTV integration site family member 3a (Wnt3a). Understanding the modulation of Shh/Wnt signaling is critical for the development of new MB treatments. Shh and Wnt3a induce MB cell proliferation and bind heparan sulfate glycosaminoglycan chains (HS-GAGs). HS-GAGs are components of syndecans, cell surface HS proteoglycans (HSPGs) which act as co-receptors for extracellular matrix-based ligands, and are targets of heparanase (HPSE). We hypothesized that extracellular HPSE activity modulates MB intracellular signaling of Shh/Wnt3a, involving syndecan-1 and -4 carboxy terminal-associated proteins and downstream targets. We compared the regulation of Shh/Wnt3a signaling subsequent to treatment with exogenous human active HPSE in MB lines possessing increased invasive abilities. We identified guanine nucleotide exchange factor-H1 (GEF-H1), a small GTPase guanine nucleotide exchange factor, as a new component of a syndecan signaling complex. Secondly, we demonstrated that HPSE modulated Shh/Wnt3-dependent expression and the intracellular distribution of GEF-H1, β-catenin and N-Myc. Thirdly, HPSE modulated Shh/Wnt3a-dependent gene expression of heparan sulfate proteoglycan (HSPG) and Gli transcription factors. Fourthly, pre-treatment with HPSE, alone or prior to Shh/Wnt3a exposure, altered small GTPase (Rac1/RhoA) activities differentially and promoted RhoA activation. Finally, the differential regulation of Rac1/RhoA activities by HPSE affected MB cell proliferation and invasion. Our results indicate that the HPSE/HSPG axis is implicated in critical MB cell signaling pathways with potential relevance for MB treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1. 

Guessous F, Li Y and Abounader R: Signaling pathways in medulloblastoma. J Cell Physiol. 217:577–583. 2008. View Article : Google Scholar

2. 

Flora A, Klisch TJ, Schuster G and Zoghbi HY: Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science. 326:1424–1427. 2009. View Article : Google Scholar : PubMed/NCBI

3. 

Ribi K, Relly C, Landolt MA, Alber FD, Boltshauser E and Grotzer MA: Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics. 36:357–365. 2005. View Article : Google Scholar : PubMed/NCBI

4. 

Marchetti D, Mrak RE, Paulsen DD and Sinnappah-Kang ND: Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion. J Exp Clin Cancer Res. 26:5–23. 2007.PubMed/NCBI

5. 

Gottardo NG and Gajjar A: Current therapy for medulloblastoma. Curr Treat Options Neurol. 8:319–334. 2006. View Article : Google Scholar

6. 

Yauch RL, Dijkgraaf GJ, Alicke B, et al: Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science. 326:572–574. 2009. View Article : Google Scholar : PubMed/NCBI

7. 

Vaillant C and Monard D: SHH pathway and cerebellar development. Cerebellum. 8:291–301. 2009. View Article : Google Scholar : PubMed/NCBI

8. 

Cool SM and Nurcombe V: Heparan sulfate regulation of progenitor cell fate. J Cell Biochem. 99:1040–1051. 2006. View Article : Google Scholar : PubMed/NCBI

9. 

Rubin JB, Choi Y and Segal RA: Cerebellar proteoglycans regulate sonic hedgehog responses during development. Development. 129:2223–2232. 2002.PubMed/NCBI

10. 

Mythreye K and Blobe GC: Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell Signal. 21:1548–1558. 2009. View Article : Google Scholar : PubMed/NCBI

11. 

O'Connell MP, Fiori JL, Kershner EK, et al: Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in meta-static melanoma cells. J Biol Chem. 284:28704–28712. 2009.PubMed/NCBI

12. 

Iozzo RV: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest. 108:165–167. 2001. View Article : Google Scholar : PubMed/NCBI

13. 

Sanderson RD and Yang Y: Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin Exp Metastasis. 25:149–159. 2008. View Article : Google Scholar : PubMed/NCBI

14. 

Beauvais DM and Rapraeger AC: Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol. 2:1–12. 2004. View Article : Google Scholar

15. 

Tkachenko E, Rhodes JM and Simons M: Syndecans: new kids on the signaling block. Circ Res. 96:488–500. 2005. View Article : Google Scholar : PubMed/NCBI

16. 

Fux L, Ilan N, Sanderson RD and Vlodavsky I: Heparanase: busy at the cell surface. Trends Biochem Sci. 34:511–519. 2009. View Article : Google Scholar : PubMed/NCBI

17. 

Ilan N, Elkin M and Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol. 38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI

18. 

Goodrich LV, Milenkovic L, Higgins KM and Scott MP: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 277:1109–1113. 1997. View Article : Google Scholar : PubMed/NCBI

19. 

Berman DM, Karhadkar SS, Hallahan AR, et al: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 297:1559–1561. 2002. View Article : Google Scholar : PubMed/NCBI

20. 

Fattet S, Haberler C, Legoix P, et al: Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol. 218:86–94. 2009. View Article : Google Scholar

21. 

Symons M and Segall JE: Rac and Rho driving tumor invasion: who's at the wheel? Genome Biol. 10:1–4. 2009.PubMed/NCBI

22. 

Sanz-Moreno V and Marshall CJ: Rho-GTPase signaling drives melanoma cell plasticity. Cell Cycle. 8:1484–1487. 2009. View Article : Google Scholar : PubMed/NCBI

23. 

Ilina O and Friedl P: Mechanisms of collective cell migration at a glance. J Cell Sci. 122:3203–3208. 2009. View Article : Google Scholar : PubMed/NCBI

24. 

Avalos AM, Valdivia AD, Munoz N, et al: Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA. J Cell Sci. 122:3462–3471. 2009. View Article : Google Scholar : PubMed/NCBI

25. 

Sinnappah-Kang ND, Kaiser AJ, Blust BE, Mrak RE and Marchetti D: Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion. Int J Oncol. 27:617–626. 2005.PubMed/NCBI

26. 

Birkenfeld J, Nalbant P, Yoon SH and Bokoch GM: Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis? Trends Cell Biol. 18:210–219. 2008. View Article : Google Scholar : PubMed/NCBI

27. 

Nardella C, Lahm A, Pallaoro M, Brunetti M, Vannini A and Steinkuhler C: Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry. 43:1862–1873. 2004. View Article : Google Scholar : PubMed/NCBI

28. 

Ridgway LD, Kim EY and Dryer SE: MAGI-1 interacts with Slo1 channel proteins and suppresses Slo1 expression on the cell surface. Am J Physiol Cell Physiol. 297:C55–C65. 2009. View Article : Google Scholar : PubMed/NCBI

29. 

Xian X, Gopal S and Couchman JR: Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. 339:31–46. 2009. View Article : Google Scholar : PubMed/NCBI

30. 

Alexander CM, Reichsman F, Hinkes MT, et al: Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet. 25:329–332. 2000. View Article : Google Scholar : PubMed/NCBI

31. 

Dovas A, Yoneda A and Couchman JR: PKCbeta-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J Cell Sci. 119:2837–2846. 2006. View Article : Google Scholar : PubMed/NCBI

32. 

Nalbant P, Chang YC, Birkenfeld J, Chang ZF and Bokoch GM: Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge. Mol Biol Cell. 20:4070–4082. 2009. View Article : Google Scholar : PubMed/NCBI

33. 

Hartsock A and Nelson WJ: Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 1778:660–669. 2008. View Article : Google Scholar : PubMed/NCBI

34. 

Alvarez-Medina R, Cayuso J, Okubo T, Takada S and Marti E: Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development. 135:237–247. 2008. View Article : Google Scholar : PubMed/NCBI

35. 

Ruiz i Altaba A, Mas C and Stecca B: The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17:438–447. 2007.PubMed/NCBI

36. 

Ridley AJ and Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:389–399. 1992. View Article : Google Scholar : PubMed/NCBI

37. 

Ridley AJ, Paterson HF, Johnston CL, Diekmann D and Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:401–410. 1992. View Article : Google Scholar : PubMed/NCBI

38. 

Sanz-Moreno V, Gadea G, Ahn J, et al: Rac activation and inactivation control plasticity of tumor cell movement. Cell. 135:510–523. 2008. View Article : Google Scholar : PubMed/NCBI

39. 

Ren Y, Li R, Zheng Y and Busch H: Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases. J Biol Chem. 273:34954–34960. 1998. View Article : Google Scholar : PubMed/NCBI

40. 

Birkenfeld J, Nalbant P, Bohl BP, Pertz O, Hahn KM and Bokoch GM: GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev Cell. 12:699–712. 2007. View Article : Google Scholar : PubMed/NCBI

41. 

Ulloa F and Marti E: Wnt won the war: antagonistic role of Wnt over Shh controls dorso-ventral patterning of the vertebrate neural tube. Dev Dyn. 239:69–76. 2009.PubMed/NCBI

42. 

Sasai K, Romer JT, Lee Y, et al: Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res. 66:4215–4222. 2006. View Article : Google Scholar : PubMed/NCBI

43. 

Ridgway LD, Wetzel MD and Marchetti D: Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells. J Cell Biochem. Aug;2010.(E-pub ahead of print).

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ridgway LD, Wetzel MD and Marchetti D: Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells. Exp Ther Med 2: 229-237, 2011.
APA
Ridgway, L.D., Wetzel, M.D., & Marchetti, D. (2011). Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells. Experimental and Therapeutic Medicine, 2, 229-237. https://doi.org/10.3892/etm.2010.189
MLA
Ridgway, L. D., Wetzel, M. D., Marchetti, D."Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells". Experimental and Therapeutic Medicine 2.2 (2011): 229-237.
Chicago
Ridgway, L. D., Wetzel, M. D., Marchetti, D."Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells". Experimental and Therapeutic Medicine 2, no. 2 (2011): 229-237. https://doi.org/10.3892/etm.2010.189
Copy and paste a formatted citation
x
Spandidos Publications style
Ridgway LD, Wetzel MD and Marchetti D: Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells. Exp Ther Med 2: 229-237, 2011.
APA
Ridgway, L.D., Wetzel, M.D., & Marchetti, D. (2011). Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells. Experimental and Therapeutic Medicine, 2, 229-237. https://doi.org/10.3892/etm.2010.189
MLA
Ridgway, L. D., Wetzel, M. D., Marchetti, D."Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells". Experimental and Therapeutic Medicine 2.2 (2011): 229-237.
Chicago
Ridgway, L. D., Wetzel, M. D., Marchetti, D."Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells". Experimental and Therapeutic Medicine 2, no. 2 (2011): 229-237. https://doi.org/10.3892/etm.2010.189
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team